Advanced Oncotherapy (AVO)

Sector:

Health Care

 1.93p
   
  • Closing Price Chg:
      0.000p
  • 52 Week High: 25.00
  • 52 Week Low: 1.75
  • Currency: UK Pounds
  • Shares Issued: 542.57m
  • Volume: 0
  • Market Cap: £10.44m

Construction advancing at Advanced Oncoptherapy's Harley Street premises

By Josh White

Date: Tuesday 30 May 2017

LONDON (ShareCast) - (ShareCast News) - Developer of next-generation proton therapy systems for cancer treatment, Advanced Oncotherapy, announced on Tuesday that excavation work at its flagship Harley Street site was progressing "well" and "on time".
The AIM-traded company said work had been completed on multiple stages of site work and demolition activity, with groundworks and piling - the longest stage in the excavation and build process for the core and shell -to follow shortly.

Advanced Oncotherapy and The Howard de Walden Estate - which was funding the demolition and reconstruction work - reportedly remained confident that the principal contractor for the project, Deconstruct UK, was on schedule to deliver to the timetable provided on 6 March.

"Deconstruct UK is highly experienced in strategic demolition; that is, preserving the integrity and appearance of a Grade 2 listed building, such as 141/143 Harley Street," the company's board said in its statement.

"The listed status of the buildings and their location add a complexity to the build that would preclude the installation of traditional proton beam therapy technology on such a site.

"LIGHT's unique feature of modularity enables it to go into Harley Street and will, just as importantly from a commercial perspective, facilitate the installation of additional LIGHT systems in existing and new radiotherapy departments globally."

Advanced Oncotherapy said the feature was most clearly demonstrated by the ability to deliver LIGHT's compact accelerating modules on site via the front door of 141/143 Harley Street, thereby removing the requirement for open-roof access and use of a crane.

"As previously outlined to shareholders, the company's first LIGHT system is due to be capable of clinical operation by Q3 2018 and installation in the Harley Street facility is expected to take place during H2 2019."

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

AVO Market Data

Currency UK Pounds
Share Price 1.93p
Closing Price Change 0.000p
% Change 0.00 %
52 Week High 25.00
52 Week Low 1.75
Volume 0
Shares Issued 542.57m
Market Cap £10.44m

AVO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
74.4% below the market average74.4% below the market average74.4% below the market average74.4% below the market average74.4% below the market average
40.54% below the sector average40.54% below the sector average40.54% below the sector average40.54% below the sector average40.54% below the sector average
Income Not Available
Growth Not Available

AVO Dividends

No dividends found

Trades for --2024

Time Volume / Share Price
0 @ 0.000p

AVO Key Personnel

CEO Nicolas Serandour

Top of Page